ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

Johnson & Johnson JOHNSON & JOHNS.../  US4781601046  /

London International
26.04.2024  19:25:35 Изменение - Объем сделки Бид26.04.2024 Предложение26.04.2024 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
146.60USD - 7,448
Оборот: 86,416.47		 -Величина цены спроса: - -Величина цены предложения: - 370.77 млрдUSD 3.05% 11.10
TeleTrader 15.10 J&J's Q3 sales rise by 5.2% to $22.5B
TeleTrader 01.10 J&J: Over $2B to be put into new facility in North Carolina
TeleTrader 10.09 D. S. Davis retires as director of Johnson & Johnson
TeleTrader 20.08 Johnson & Johnson to buy V-Wave for up to $1.7B
GlobeNewswire 14.08 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
TeleTrader 17.07 J&J's Q2 sales up by 4.3% to $22.4 billion
GlobeNewswire 28.05 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 01.05 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 17.04 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 10.04 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 05.04 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 26.03 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 15.03 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 06.03 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 27.01 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 24.01 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 23.01 J&J to pay $700M in talc powder probe settlement
TeleTrader 23.01 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 23.01 Johnson & Johnson Q4 earnings preview
TeleTrader 22.01 Earnings preview: Tesla takes center stage
TeleTrader 08.01 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 04.12.2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 04.12.2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 07.11.2023 J&J to begin trials with surgical robot
TeleTrader 17.10.2023 J&J's Q3 sales up 6.8% to $21.4 billion